The promise of SGLT2 inhibitors
SGLT2, a protein in the kidney, takes glucose out of the urine and puts it in the blood. Blocking this reduces diabetes, heart disease, and kidney disease – but we’re not exactly sure why.
Natália Coelho Mendonça
Natália Coelho Mendonça is a software engineer and blogger based in San Francisco.
Flozins
Follow on TwitterRead more →